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Using Nucleic Acid-Gold Nanoparticle Conjugates in the Fight Against Bacteria that are Resistant to 
Tetracycline AntibioticsAllen Livingston (2023) Mentor: Dr. Timea Fernandez
Abstract
Antibiotic resistance is major problem in modern medicine. Seventy percent of bacterial strains 
are resistant to at least one antibiotic, making treatment of bacterial infections ever more 
expensive and difficult. Currently, we are investigating the therapeutic potency of nucleic acid-
gold nanoparticle conjugates as treatments against bacteria that are resistant to the antibiotic 
tetracycline. We hypothesize that by attaching RNA that binds to tetracycline to silver or gold 
nanoparticles the resulting conjugates will work as a “Trojan-horse” tetracycline-delivery 
vehicle that smuggles the antibiotic into the cell without being detected by cellular defense 
systems. Moreover, we reason that silver or gold ions released by the nanoparticles add to the 
antimicrobial effects of tetracycline.
To demonstrate the viability of this idea, we set out to generate a nuclease resistant variant 
of the tetracycline binding RNA ykkCD and attach it to gold nanoparticles. During the summer 
we furthered the progress of this research in there major ways. First, we optimized conditions 
used for the polymerase chain reaction that generates the DNA template for RNA synthesis. 
Second, we found the most efficient way to synthesize RNA containing modified nucleotides. 
Usage of modified nucleotides is necessary to prevent degradation of the tetracycline-binding 
RNA by cellular nucleases. Third, we optimized a stability assay to verify that the modified 
RNAs are stable in cellular environments. Fourth, we attached the tetracycline binding RNA to 
gold nanoparticles.
The next steps in the process would be to test the potency of this modified RNA-gold 
nanoparticle conjugate against a tetracycline-resistant strain of the bacteria E. Coli.
What are nanoparticles?
Nanoparticles are particles that vary in size from 1nm-
100nm, they are also tools that detect and deliver small 
molecules. They are used in our work to transport medicine 
to bacteria that would normally be resistant to the medicine.
Antibiotic resistance is a problem in medicine. Seventy 
percent of bacterial strains are resistant to at least one 
antibiotic, making treatment of bacterial infections ever 




• Optimized the synthesis of template DNA.
• Optimized the conditions used to synthesize RNA. 
• Demonstrated that modified RNA is resistant to cellular 
nucleases.
• Attached gold nanoparticles to RNA.
Future goals
• We will make more of this Au-modified RNA nanoparticle 
conjugate and test its efficacy on tet resistant E Coli.
• We will try other tet-binding aptamers. We will use 
secondary structure prediction and optimize the length of 
the linker between the tet-binding aptamer and the sequence 
that targets the RNA to the ribosome. We will aim for a 
setup that maintain the structure both aptamers. 
RNA was successfully attached to gold 
nanoparticles 
A slower migration of the RNA-AuNP conjugate compared to 
AuNPs alone (gel retardation) indicates that the RNA was attached 
to the nanoparticles
RNA synthesis was most efficient 
with 12ng/µl DNA, excess Mg2+
and nucleotides.
To optimize in vitro RNA synthesis we varied the 
following parameters. The first optimization involved how 
much the concentration of template DNA affected the 
production of RNA. The second optimization varied the 
amount of Mg2+ and NTP concentration and used modified 
nucleotides. We found that 12ng/µl DNA, 20mM Mg2+ and 
4mM NTP produced optimal RNA yield.
DNA synthesis was most efficient 
with high template concentration
To optimize in vitro DNA synthesis using PCR we varied 
the concentration of the DNA template, Mg2+ and tested 
whether the addition of DMSO increases DNA yield. We 
found that elevated template DNA concertation increased 
PCR yield but other additives did not.
Why is the RNA modified?
RNA aptamers that are used as treatment have to be 
resistant to cellular nucleases to exert their function. 
Natural RNA nucleotides are replaced with 2’ modified 
ones to avoid self-cleavage of RNA. 
The tet-binding RNA aptamer is 
resistant to cellular nucleases
To assess the stability of the tet-binding aptamer in 
biological fluids we incubated the RNA with 10% bovine 
serum for 80 minutes at 37°C. Start and end point samples 
were compared on a denaturing PAGE. Modified RNA 
samples only show slight degradation as indicated by a 
single band that co-migrates with the start point samples. 
Unmodified RNA (last sample) appears completely 
degraded as it does not appear to be present in the end-point 
sample.
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Figure 7. RNA stability 
assay. From left to right (1) 
RNA molecular weight 
ladder, (2) dUTP RNA 
untreated, (3) dUTP RNA 
treated, (4) 2’-F-dUTP RNA 
untreated, (5) 2’-F-dUTP 
RNA treated.
Usage of RNA aptamers in 
medicine
We propose that using nucleic acid-gold nanoparticle 
conjugates could be an effective way to treat 
antibiotic-resistant bacterial infections. We 
hypothesize that the tet-binding RNA aptamer will 
deceive tet-resistant cells to uptake tetracycline by 
acting as a caging compound. The tet-binding aptamer
is attached to gold nanoparticles, because bacteria is 
known to uptake nanoparticles 4-40nm in size using 
receptor mediated endocytosis. In addition to the 
cytotoxic affect of tetracycline, the Ag+ ions released 
form the nanoparticle will add to the antimicrobial 
effect of tetracycline. 
Tet-aptamer RNA
Figure 8. Attachment of RNA to gold 
nanoparticles. From left to right. (1) gold 
nanoparticles, (2) 2-F’-dUTP RNA-gold 
nanoparticle conjugates and (3) dUTP
RNA-gold nanoparticle conjugates. 
Samples were run on a 1% agarose gel for 
60min at 100V.
Figure 5: Optimization on 
template DNA synthesis with 
PCR. From left to right with (1) 
DNA ladder, (2) low template 
mixture, (3) high template 
mixture, (4) extra Mg²+, (5) 
DMSO and (6) no enzyme 
negative control. The samples 
were resolved on a 1% agarose 
gel that was ran at 100V for 30 
minutes.
Figure 4: Left panel: RNA is prone to degradation 
because the 2’OH act as nucleophile to attack the 
adjacent phosphodiester bond and cleave the backbone 
(red arrow). Right panel. Modified RNA nucleotides. 
2’-fluoro modified nucleotides are used in this project.
Figure 2: Schematic describing the versatile 
applications of nanoparticles.
Figure 1: Mechanism of bacterial antibiotic resistance.
Figure 3: Schematics showing how the tet-binding 
RNA aptamer is attached to nanoparticles and expected 
to exert is antibacterial function.
Figure 6: Optimization of RNA synthesis. Left 
panel: (1) DNA Ladder (2) no enzyme, (3) 1mM 
NTP, 5mM Mg2+, (4) 1mM NTP, 20mM Mg2+, (5) 
4mM NTP, 5mM Mg2+ and (6) 20 mM Mg2+, 4mM 
NTP. Right panel: (1) DNA Ladder (2) No Enzyme 
(3) 6ng/µl DNA (4) 12 ng/µl  DNA (5) 15 ng/µl 
DNA. Samples were resolved on a 10% denaturing 
PAGE run for 30min with 15W.
